Head and Neck Cancer Is Known To Originate In Flat Squamous Cells That Make Up the Skin on the Surface of the Head and Neck
Early
detection and treatment are the keys to successful head and neck cancer
treatment. Three-quarters of head and neck cancers are detectable during a
physical examination. To find the source of the disease, healthcare providers
perform a physical exam and order diagnostic tests. During the physical
examination, healthcare providers look for any abnormalities in the neck,
tongue, throat, or oral cavity. Laboratory tests may also be performed on
samples of tissue.
According
to Coherent Market Insights the Head
and Neck Cancer Market Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2022-2028.
Most types
of head and neck cancer originates in flat squamous cells. These cells make up
the skin on the surface of the head and neck. Mucosa is the moist tissue in
these areas. If cancer is detected in this layer, it is referred to as a
carcinoma in situ. If it has spread deeper tissue, it is known as invasive
squamous cell carcinoma. Cancers of unknown primary are also rare however, may
occur in the head and neck. Head and neck cancer includes many types of throat,
larynx, and nose cancer. It may also develop in salivary glands, nose, and
sinuses. Treatment options depend on the specific type of head and neck cancer
that patients have. Most cancers of the head and neck can be cured if detected
early. The most common risk factors are tobacco, alcohol, and the human
papillomavirus.
While the
goal of head and neck cancer treatment is to treat the cancer, doctors are also
concerned with the quality of life after treatment. While radiation therapy and
surgery often result in changes in voice, doctors also focus on the function of
the neck and face and helping the patient return to normal activities. This
process of rehabilitation is an integral part of the recovery process and the
specific goals are determined by the type and extent of the disease. While the
surgery will impact a patient's ability to talk, swallow, or chew, these
changes will often improve over time. Recently in June 2022, a specialist team
of head and neck cancer at the UT Southwestern Medical Center in the U.S.
launched a first randomized study of daily adaptive radiation therapy that will
use Ethos technology of Varian to treat head and neck cancer in patients.
Comments
Post a Comment